Date:2/9/2009

===== ===== Diluted earnings per share Continuing operations $1.21 $0.69 $3.01 $3.27 Discontinued operations - - - 0.03 ---- ---- ---- ---- Diluted earnings per share $1.21 $0.69 $3.01 $3.30 ===== ===== ===== ===== Weighted average number of shares outstanding (in thousands) Basic 63,081 62,879 62,969 62,505 Diluted 63,817 64,535 64,348 64,066 BECKMAN COULTER, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in millions) (unaudited) December 31, December 31, 2008 2007 ------------ ------------ Assets Current assets Cash and cash equivalents $120.0 $83.0 Trade and other receivables, net 706.7 726.5 Inventories 496.2 523.9 Deferred income taxes 62.5 79.2 Prepaids and other current assets 76.3 75.5 ---- ---- Total current assets 1,461.7 1,488.1 Property, plant and equipment, net 914.2 867.4 Goodwill 696.3 707.4 Other intangible assets, net 396.8 418.4 Deferred income taxes 32.3 - Other as
'/>"/>

SOURCE Beckman Coulter - IR Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards